| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | 0.069 | 0.07 |
| mRNA | Rapamycin | GDSC1000 | pan-cancer | AAC | 0.094 | 0.07 |
| mRNA | GSK4112 | CTRPv2 | pan-cancer | AAC | 0.068 | 0.07 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.063 | 0.07 |
| mRNA | MI-2 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.07 |
| mRNA | BRD8958 | CTRPv2 | pan-cancer | AAC | 0.071 | 0.08 |
| mRNA | KIN001-102 | GDSC1000 | pan-cancer | AAC | 0.054 | 0.08 |
| mRNA | purmorphamine | CTRPv2 | pan-cancer | AAC | 0.068 | 0.08 |
| mRNA | erismodegib | CTRPv2 | pan-cancer | AAC | 0.068 | 0.08 |
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | -0.066 | 0.08 |